Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807702 · ClinicalTrials.gov registry record · Phase 1
13C-Pyruvate Breath Test
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01807702: Completed Phase 1 study, sponsored by University of Florida.
NCT01807702 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01807702, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of the test is to measure an enzyme called pyruvate. Subjects will fast for 12 hours and then undergo a breath test, have blood drawn, and cells from the inside of the mouth collected over a 12 hour period. The tests will be repeated at least a week later and subjects receive a dose of dichloroacetate (DCA)
Primary Outcome
Dichloroacetate is an activator of pyruvate dehydrogenase (PDH). It will be administered to the patient who will then undergo the pyruvate breath test to measure the amount of 13CO2 expressed. The activity of 13CO2 as measured by a concentration curve will reflect PDH activity.
Interventions
- DRUG 13C-Pyruvate 13C-lactate and dichloroacetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-03 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
What the finished NCT01807702 record still lists
NCT01807702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which 13C-Pyruvate 13C-lactate and dichloroacetate is the first listed.
NCT01807702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01807702 about?
NCT01807702 is a clinical study titled "13C-Pyruvate Breath Test". The purpose of the test is to measure an enzyme called pyruvate. Subjects will fast for 12 hours and then undergo a breath test, have blood drawn, and cells from the inside of the mouth collected over a 12 hour period. The tests will be repeated at least a week later and subjects receive a dose of d...
What is the current status of trial NCT01807702?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2013-03. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01807702?
The interventions under investigation include: 13C-Pyruvate 13C-lactate and dichloroacetate (DRUG).
Who is sponsoring clinical trial NCT01807702?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01807702's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia